2010-12-20 00:00:00,Gilead To Acquire Arresto Biosciences For Million
2010-12-22 00:00:00,Gilead Terminates Phase III Clinical Trial Of Ambrisentan In Patients With Idiopathic Pulmonary Fibrosis
2011-01-25 00:00:00,Gilead Announces Share Repurchase Program
2011-02-10 00:00:00,Gilead Refiles New Drug Application With FDA For Regimen of Truvada
2011-04-04 00:00:00,Hospitalization Not Cut By Gilead Heart
2011-04-20 00:00:00,Gilead And MicroDose Therapeutx Announce License And Collaboration Agreement To Develop For Treatment Of Respiratory Syncytial Virus
2011-07-12 00:00:00,Ranbaxy Laboratories Limited Announces Licensing Agreement With Gilead Inc
2011-08-15 00:00:00,Gilead Announces Result Of Phase 3 Clinical Trial Of Investigational Antiretroviral Quad Regimen
2011-11-15 00:00:00,Gilead Finalizes Agreement With Tibotec Pharmaceuticals To Develop And Commercialize Regimen Of Prezista With Emtriva
2011-12-06 00:00:00,Gilead Prices Billion Of Senior Unsecured Notes
2011-12-09 00:00:00,Gilead Announces Data From Pivotal Phase 3 Study Of Elvitegravir
2011-12-15 00:00:00,Gilead Submits Supplemental New Drug Application To Food And Drug Administration For Truvada For Reducing Risk Of Acquiring HIV
2011-12-22 00:00:00,JAPAN TOBACCO Signs License Contract for Cobicistat
2012-02-02 00:00:00,Gilead Issues FY 2012 Product Sales Call
2012-02-14 00:00:00,Gilead Announces FDA Grants Priority Review For Truvada For Reducing The Risk Of Acquiring HIV Infection
2012-03-09 00:00:00,Data Show Gilead Quad Regimen For HIV To Regimen At 48 Weeks In Second Pivotal Phase 3 Study
2012-08-27 00:00:00,FDA Approves Gilead Sciences Stribild
2012-09-12 00:00:00,Gilead Sciences Inc Reaffirms FY 2012 Revenue Call
2012-10-04 00:00:00,Option Alcatel Gilead and Vringo
2012-10-26 00:00:00,Research Weekly Ratings Changes for Gilead Sciences
